231 related articles for article (PubMed ID: 18826358)
1. Dosing and safety of cyclosporine in patients with severe brain injury.
Hatton J; Rosbolt B; Empey P; Kryscio R; Young B
J Neurosurg; 2008 Oct; 109(4):699-707. PubMed ID: 18826358
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial.
Mazzeo AT; Brophy GM; Gilman CB; Alves OL; Robles JR; Hayes RL; Povlishock JT; Bullock MR
J Neurotrauma; 2009 Dec; 26(12):2195-206. PubMed ID: 19621985
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A disposition following acute traumatic brain injury.
Empey PE; McNamara PJ; Young B; Rosbolt MB; Hatton J
J Neurotrauma; 2006 Jan; 23(1):109-16. PubMed ID: 16430377
[TBL] [Abstract][Full Text] [Related]
4. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial.
Xiao G; Wei J; Yan W; Wang W; Lu Z
Crit Care; 2008; 12(2):R61. PubMed ID: 18447940
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine for induction of remission in Crohn's disease.
McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK
Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of gacyclidine. A multicenter double-blind pilot trial in patients with acute traumatic brain injury.
Lepeintre JF; D'Arbigny P; Mathé JF; Vigué B; Loubert G; Delcour J; Kempf C; Tadié M
Neurochirurgie; 2004 Jun; 50(2-3 Pt 1):83-95. PubMed ID: 15213636
[TBL] [Abstract][Full Text] [Related]
7. Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.
Rowell SE; Meier EN; McKnight B; Kannas D; May S; Sheehan K; Bulger EM; Idris AH; Christenson J; Morrison LJ; Frascone RJ; Bosarge PL; Colella MR; Johannigman J; Cotton BA; Callum J; McMullan J; Dries DJ; Tibbs B; Richmond NJ; Weisfeldt ML; Tallon JM; Garrett JS; Zielinski MD; Aufderheide TP; Gandhi RR; Schlamp R; Robinson BRH; Jui J; Klein L; Rizoli S; Gamber M; Fleming M; Hwang J; Vincent LE; Williams C; Hendrickson A; Simonson R; Klotz P; Sopko G; Witham W; Ferrara M; Schreiber MA
JAMA; 2020 Sep; 324(10):961-974. PubMed ID: 32897344
[TBL] [Abstract][Full Text] [Related]
8. Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke.
Dyker AG; Lees KR
Stroke; 1999 Sep; 30(9):1796-801. PubMed ID: 10471426
[TBL] [Abstract][Full Text] [Related]
9. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group.
Marmarou A; Nichols J; Burgess J; Newell D; Troha J; Burnham D; Pitts L
J Neurotrauma; 1999 Jun; 16(6):431-44. PubMed ID: 10391361
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective use.
Cook AM; Whitlow J; Hatton J; Young B
Expert Opin Drug Saf; 2009 Jul; 8(4):411-9. PubMed ID: 19548859
[TBL] [Abstract][Full Text] [Related]
11. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury.
Wright DW; Kellermann AL; Hertzberg VS; Clark PL; Frankel M; Goldstein FC; Salomone JP; Dent LL; Harris OA; Ander DS; Lowery DW; Patel MM; Denson DD; Gordon AB; Wald MM; Gupta S; Hoffman SW; Stein DG
Ann Emerg Med; 2007 Apr; 49(4):391-402, 402.e1-2. PubMed ID: 17011666
[TBL] [Abstract][Full Text] [Related]
12. Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
Presneill J; Little L; Nichol A; French C; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R; ;
Trials; 2014 Dec; 15():501. PubMed ID: 25528574
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury.
Merchant RE; Bullock MR; Carmack CA; Shah AK; Wilner KD; Ko G; Williams SA
Ann N Y Acad Sci; 1999; 890():42-50. PubMed ID: 10668412
[TBL] [Abstract][Full Text] [Related]
14. Copenhagen Head Injury Ciclosporin Study: A Phase IIa Safety, Pharmacokinetics, and Biomarker Study of Ciclosporin in Severe Traumatic Brain Injury Patients.
Kelsen J; Karlsson M; Hansson MJ; Yang Z; Fischer W; Hugerth M; Nordström CH; Åstrand R; Keep MF; Kilbaugh T; Wang KKW; Møller K; Juhler M; Elmér E
J Neurotrauma; 2019 Dec; 36(23):3253-3263. PubMed ID: 31210099
[TBL] [Abstract][Full Text] [Related]
15. Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study.
Mazzeo AT; Alves OL; Gilman CB; Hayes RL; Tolias C; Niki Kunene K; Ross Bullock M
Acta Neurochir (Wien); 2008 Oct; 150(10):1019-31; discussion 1031. PubMed ID: 18781275
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine before Coronary Artery Bypass Grafting Does Not Prevent Postoperative Decreases in Renal Function: A Randomized Clinical Trial.
Ederoth P; Dardashti A; Grins E; Brondén B; Metzsch C; Erdling A; Nozohoor S; Mokhtari A; Hansson MJ; Elmér E; Algotsson L; Jovinge S; Bjursten H
Anesthesiology; 2018 Apr; 128(4):710-717. PubMed ID: 29369890
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
[TBL] [Abstract][Full Text] [Related]
18. Progesterone for acute traumatic brain injury.
Ma J; Huang S; Qin S; You C; Zeng Y
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008409. PubMed ID: 28005271
[TBL] [Abstract][Full Text] [Related]
19. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury.
Natale JE; Guerguerian AM; Joseph JG; McCarter R; Shao C; Slomine B; Christensen J; Johnston MV; Shaffner DH
Pediatr Crit Care Med; 2007 Jan; 8(1):1-9. PubMed ID: 17251875
[TBL] [Abstract][Full Text] [Related]
20. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial.
Temkin NR; Anderson GD; Winn HR; Ellenbogen RG; Britz GW; Schuster J; Lucas T; Newell DW; Mansfield PN; Machamer JE; Barber J; Dikmen SS
Lancet Neurol; 2007 Jan; 6(1):29-38. PubMed ID: 17166799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
